425 related articles for article (PubMed ID: 28506760)
1. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.
McAdoo SP; Tanna A; Hrušková Z; Holm L; Weiner M; Arulkumaran N; Kang A; Satrapová V; Levy J; Ohlsson S; Tesar V; Segelmark M; Pusey CD
Kidney Int; 2017 Sep; 92(3):693-702. PubMed ID: 28506760
[TBL] [Abstract][Full Text] [Related]
2. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
[TBL] [Abstract][Full Text] [Related]
3. A "double-seropositive" Vasculitis for antiglomerular basement membrane antibodies and antineutrophil cytoplasmic antibody, and multiple myeloma, all three with simultaneous diagnosis of renal involvement, common pathophysiology, or pure coincidence? first case in the World.
Chettati M; Adnouni A; Bouchemla N; Anibar S; Fadili W; Laouad I
Saudi J Kidney Dis Transpl; 2019; 30(4):953-959. PubMed ID: 31464254
[TBL] [Abstract][Full Text] [Related]
4. ANCA associated vasculitis: experience of a tertiary care referral center.
Chaudhry R; Bilal A; Austin A; Mehta S; Salman L; Foulke L; Feustel P; Zuckerman R; Asif A
J Bras Nefrol; 2019; 41(1):55-64. PubMed ID: 30095143
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies.
Levy JB; Hammad T; Coulthart A; Dougan T; Pusey CD
Kidney Int; 2004 Oct; 66(4):1535-40. PubMed ID: 15458448
[TBL] [Abstract][Full Text] [Related]
6. Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort.
Alchi B; Griffiths M; Sivalingam M; Jayne D; Farrington K
Nephrol Dial Transplant; 2015 May; 30(5):814-21. PubMed ID: 25609740
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody.
Srivastava A; Rao GK; Segal PE; Shah M; Geetha D
Clin Rheumatol; 2013 Sep; 32(9):1317-22. PubMed ID: 23624587
[TBL] [Abstract][Full Text] [Related]
8. Anti-hLAMP2-antibodies and dual positivity for anti-GBM and MPO-ANCA in a patient with relapsing pulmonary-renal syndrome.
Etter C; Gaspert A; Regenass S; Wüthrich RP; Kistler T; Kain R; Cohen CD
BMC Nephrol; 2011 Jun; 12():26. PubMed ID: 21651778
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients.
Hu X; Shen C; Meng T; Ooi JD; Eggenhuizen PJ; Zhou YO; Luo H; Chen JB; Lin W; Gong Y; Xiong Q; Xu J; Liu N; Xiao X; Tang R; Zhong Y
Front Immunol; 2022; 13():991469. PubMed ID: 36389826
[TBL] [Abstract][Full Text] [Related]
10. [ANCA and anti-MBG double-positive vasculitis: An update on the clinical and therapeutic specificities and comparison with the two eponymous vasculitis].
Philip R; Dumont A; Le Mauff B; Martinet M; Martin Silva N; de Boysson H; Lobbedez T; Aouba A; Deshayes S
Rev Med Interne; 2020 Jan; 41(1):21-26. PubMed ID: 31839271
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
[TBL] [Abstract][Full Text] [Related]
12. Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis.
Clerte M; Philip R; Levi C; Cornec-Le Gall E; Audard V; Huart A; Puéchal X; Touzot M; Rabot N; Thervet É; Aouba A; Karras A
Scand J Rheumatol; 2022 May; 51(3):205-213. PubMed ID: 34169779
[TBL] [Abstract][Full Text] [Related]
13. Incidence and features of dual anti-GBM-positive and ANCA-positive patients.
DE Zoysa J; Taylor D; Thein H; Yehia M
Nephrology (Carlton); 2011 Nov; 16(8):725-9. PubMed ID: 21649794
[TBL] [Abstract][Full Text] [Related]
14. Predicting Outcome in Patients with Anti-GBM Glomerulonephritis.
van Daalen EE; Jennette JC; McAdoo SP; Pusey CD; Alba MA; Poulton CJ; Wolterbeek R; Nguyen TQ; Goldschmeding R; Alchi B; Griffiths M; de Zoysa JR; Vincent B; Bruijn JA; Bajema IM
Clin J Am Soc Nephrol; 2018 Jan; 13(1):63-72. PubMed ID: 29162595
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics and predictors of poor outcome in anti-glomerular basement membrane disease - a fifteen year single center experience.
Zahir Z; Wani AS; Prasad N; Jain M
Ren Fail; 2021 Dec; 43(1):79-89. PubMed ID: 33334228
[TBL] [Abstract][Full Text] [Related]
16. Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis.
Gregersen JW; Kristensen T; Krag SR; Birn H; Ivarsen P
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S39-47. PubMed ID: 22510451
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
[TBL] [Abstract][Full Text] [Related]
18. Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases.
Nakabayashi K; Fujioka Y; Nagasawa T; Kimura T; Kojima K; Arimura Y; Yamada A
Clin Exp Nephrol; 2011 Apr; 15(2):226-34. PubMed ID: 21246240
[TBL] [Abstract][Full Text] [Related]
19. A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchange.
Ikeda Y; Fukunari K; Uchiumi S; Awanami Y; Kanaya A; Matsumoto K; Fukuda M; Takashima T; Miyazono M; Ikeda Y
CEN Case Rep; 2020 Feb; 9(1):42-47. PubMed ID: 31612361
[TBL] [Abstract][Full Text] [Related]
20. Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study.
Cui Z; Zhao J; Jia XY; Zhu SN; Jin QZ; Cheng XY; Zhao MH
Medicine (Baltimore); 2011 Sep; 90(5):303-311. PubMed ID: 21862934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
